BRCA2 and cancer: BRCA2 inactivation by cancer-associated mutations or RNAi-mediated depletion subverts this mechanism, impeding transcription elongation at the PPP sites of actively transcribed genes, accompanied by R-loop accumulation and DNA breakage mediated by the ERCC4 nuclease.